About
Investors:
IR@teladochealth.com
Source:
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.01 USD | -2.40% | +0.23% | -39.63% |
Apr. 26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
Apr. 26 | Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating | MT |
About
Investors:
IR@teladochealth.com
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-39.63% | 2.21B | |
+40.45% | 2.68B | |
+22.83% | 527M | |
+42.77% | 467M | |
-64.56% | 157M | |
-31.65% | 85.12M |